Literature DB >> 2653692

Clinical significance of antibiotic tissue penetration.

J J Schentag1.   

Abstract

The concentrations achieved by a particular antibiotic in serum and tissues can be predicted from pharmacokinetic data. These predictions must be evaluated in the broader context of the patient's infection, particularly the MIC of the drug for the infecting organism. What is the relevant measurement - the serum concentration or the tissue to serum ratio? Are the serum and/or tissue concentrations achieved at the site of infection sufficiently in excess of the MIC to eradicate the organism? How long are these levels sustained? How often must the drug be given to keep the concentrations sufficiently in excess of the MIC to eradicate the organisms? This presentation will review these questions in the context of the major classes of antibiotics: the beta-lactams, aminoglycosides and quinolones.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2653692     DOI: 10.2165/00003088-198900161-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  39 in total

Review 1.  A review of the penetration of antibiotics into CSF and its clinical significance.

Authors:  R Norrby
Journal:  Scand J Infect Dis Suppl       Date:  1978

Review 2.  Antibiotic assays in muscle: are conventional tissue levels misleading as indicator of the antibacterial activity?

Authors:  D M Ryan; O Cars
Journal:  Scand J Infect Dis       Date:  1980

Review 3.  Principles of antibiotic tissue penetration and guidelines for pharmacokinetic analysis.

Authors:  J J Schentag; F M Gengo
Journal:  Med Clin North Am       Date:  1982-01       Impact factor: 5.456

4.  The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.

Authors:  R Wise; A P Gillett; B Cadge; S R Durham; S Baker
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

5.  Prevention of pyelonephritis due to Escherichia coli in rats with gentamicin stored in kidney tissue.

Authors:  M P Glauser; J M Lyons; A I Braude
Journal:  J Infect Dis       Date:  1979-02       Impact factor: 5.226

6.  Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia.

Authors:  E T Anderson; L S Young; W L Hewitt
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

7.  Rate of methicillin penetration into normal heart valve and experimental endocarditis lesions.

Authors:  F M Gengo; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

8.  Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimens.

Authors:  J P McCormack; J J Schentag
Journal:  Drug Intell Clin Pharm       Date:  1987-02

9.  Gentamicin tissue accumulation and nephrotoxic reactions.

Authors:  J J Schentag; T J Cumbo; W J Jusko; M E Plaut
Journal:  JAMA       Date:  1978-11-03       Impact factor: 56.272

10.  Dosage schedules of antimicrobial agents: a historical review.

Authors:  C M Kunin
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb
View more
  26 in total

Review 1.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

2.  Quantitative morphology and water distribution of bronchial biopsy samples.

Authors:  D R Baldwin; R Wise; J M Andrews; D Honeybourne
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

Review 3.  Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 4.  Pharmacokinetic changes during pregnancy and their clinical relevance.

Authors:  R Loebstein; A Lalkin; G Koren
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 5.  Optimum treatment of streptococcal pharyngitis.

Authors:  F Scaglione; G Demartini; M M Arcidiacono; J P Pintucci
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

6.  Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.

Authors:  F Scaglione; G Demartini; S Dugnani; M M Arcidiacono; J P Pintucci; F Fraschini
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

7.  Behavior of antibiotics during human necrotizing pancreatitis.

Authors:  C Bassi; P Pederzoli; S Vesentini; M Falconi; A Bonora; H Abbas; A Benini; E M Bertazzoni
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  Measurement of cefaclor and amoxicillin-clavulanic acid levels in middle-ear fluid in patients with acute otitis media.

Authors:  F Scaglione; D Caronzolo; J P Pintucci; F Fraschini
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

9.  Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state.

Authors:  K Stoeckel; M Harell; M Dan
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 10.  Cefetamet pivoxil clinical pharmacokinetics.

Authors:  R A Blouin; K Stoeckel
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.